Suchergebnisse - (Person:"Ma, Qingfeng")

PubPharm (7)

1

Intermittent hypoxia preconditioning can attenuate acute hypoxic injury after a sustained normobaric hypoxic exposure : A randomized clinical trial

enthalten in: CNS neuroscience & therapeutics | 2024

von Wang, Y. | Zhang, Q. | Ma, Q. | +3

2

Thrombolysis with Recombinant Human Prourokinase 4.5-6 h After Acute Ischemic Stroke : A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial

enthalten in: CNS drugs | 2024

von Song, H. | Wang, Y. | Ma, Q. | +15

3

Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset : A Phase 3 Randomized Clinical Trial

enthalten in: JAMA network open | 2023

von Song, H. | Wang, Y. | Ma, Q. | +47

4

Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke : A Phase IIa Randomized Clinical Trial

enthalten in: Translational stroke research | 2022

von Song, H. | Wang, Y. | Ma, Q. | +24

5

Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion

enthalten in: The New England journal of medicine | 2022

von Jovin, T. | Li, C. | Wu, L. | +144

CommentIn: N Engl J Med. 2022 Oct 13;387(15):1428-1429. - PMID 36239649

6

Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke : A Randomized Controlled Clinical Trial

enthalten in: Neurology | 2022

von Li, W. | Qi, Z. | Ma, Q. | +16

CommentIn: Neurology. 2022 Dec 6;99(23):1068-1069. - PMID 36719722

7

Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage : A proof-of-concept randomized controlled trial

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2022

von Zhao, W. | Jiang, F. | Li, S. | +14

1
[1]